1. Доктор Марк Липпман. Специалист в области гормональной терапии рака молочной железы. Биография.
Dr. Marc Lippman, MD, explains the evolution of endocrine treatment. He is a professor of oncology and medicine at Georgetown University.
▶⏸
2. Гормональная терапия при раке молочной железы: история и достижения.
Dr. Marc Lippman, MD, explains the history and current state of endocrine treatments. He details how hormone-dependent breast cancer was first observed centuries ago.
▶⏸
3. Как предотвратить 70% случаев рака молочной железы? Тамоксифен. Ингибиторы ароматазы.
Dr. Marc Lippman, MD, explains how anti-hormonal therapies can prevent up to 70% of breast cancers. He details the profound impact of estrogen exposure duration...
▶⏸
4. Breast cancer hormone therapy. Tamoxifen vs. Anastrozole? 3
Dr. Marc Lippman, MD, explains the choice between Tamoxifen and aromatase inhibitors like anastrozole. He details the specific use cases for each medication based on...
▶⏸
5. Breast cancer hormone therapy. LHRH agonists. Tamoxifen. SERDs. Aromatase inhibitors. SERMs. 4
Dr. Marc Lippman, MD, explains the major classes of endocrine medications. He details the use of LHRH agonists, SERMs, SERDs, and aromatase inhibitors.
▶⏸
6. When can breast cancer be considered cured? Is cure possible for breast cancer? 5
Dr. Marc Lippman, MD, explains the concept of cure in oncology. He clarifies that the five-year disease-free milestone is not a universal standard for cure....
▶⏸
7. Гормональная терапия при раке молочной железы. Продолжительность приёма ингибиторов ароматазы: 5 или 10 лет? Эстрогены способствуют росту опухоли молочной железы.
Dr. Marc Lippman, MD, explains the complex roles of estrogens and progestins in breast cancer development. He details how estrogens act as promoters of cancer...
▶⏸
8. Гормональная терапия рака молочной железы. Применение прогестинов для профилактики и лечения рака молочной железы? 7
Dr. Marc Lippman, MD, explains the complex role of progestins and anti-progestins in breast cancer treatment. He details the clinical and political challenges surrounding anti-progestin...
▶⏸
9. Гормональная терапия при раке молочной железы. Как подобрать ингибиторы ароматазы?
Dr. Marc Lippman, MD, explains how to choose aromatase inhibitors. He details the lack of clinical difference between steroidal and non-steroidal types.
▶⏸
10. Гормональная терапия рака молочной железы: агонисты люлиберина (LHRH) или двусторонняя сальпингоофорэктомия (ДСО)?
Dr. Marc Lippman, MD, explains ovarian suppression methods for premenopausal patients. He details the choice between LHRH agonists and bilateral salpingo-oophorectomy (BSO).
▶⏸
11. Breast cancer treatment. How to select neoadjuvant and adjuvant chemotherapy? 10
Dr. Marc Lippman, MD, explains the selection of neoadjuvant and adjuvant chemotherapy protocols. He details the significant advantages of administering systemic therapy before surgery.
▶⏸
12. Иммунотерапия при раке молочной железы. Иммунотерапия не является универсальным решением. 11
Dr. Marc Lippman, MD, explains the current state and limitations of immune checkpoint inhibitors in breast cancer treatment. He details the qualitative differences in response...
Уточните план лечения, проконсультировавшись с ведущими специалистами, которые полностью соответствуют вашему клиническому случаю.
